{"id":"https://openalex.org/W2000152337","doi":"https://doi.org/10.1016/j.drugpo.2007.01.007","title":"Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study","display_name":"Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study","publication_year":2007,"publication_date":"2007-02-22","ids":{"openalex":"https://openalex.org/W2000152337","doi":"https://doi.org/10.1016/j.drugpo.2007.01.007","mag":"2000152337","pmid":"https://pubmed.ncbi.nlm.nih.gov/17854736"},"language":"en","primary_location":{"id":"doi:10.1016/j.drugpo.2007.01.007","doi":"https://doi.org/10.1016/j.drugpo.2007.01.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drugpo.2007.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S60503757","display_name":"International Journal of Drug Policy","issn_l":"0955-3959","issn":["0955-3959","1873-4758"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Policy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://handle.unsw.edu.au/1959.4/unsworks_46780","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103076687","display_name":"Oanh Kieu Nguyen","orcid":"https://orcid.org/0000-0002-4614-0215","observed_orcids":["https://orcid.org/0000-0002-4614-0215"]},"institutions":[{"id":"https://openalex.org/I145902186","display_name":"Burnet Institute","ror":"https://ror.org/05ktbsm52","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I145902186"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Oanh K. Nguyen","raw_affiliation_strings":["Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Vic., Australia. oanh@burnet.edu.au","Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Vic., Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Vic., Australia. oanh@burnet.edu.au","institution_ids":["https://openalex.org/I145902186"]},{"raw_affiliation_string":"Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Vic., Australia","institution_ids":["https://openalex.org/I145902186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052909853","display_name":"Gregory J. Dore","orcid":"https://orcid.org/0000-0002-4741-2622","observed_orcids":["https://orcid.org/0000-0002-4741-2622"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Gregory J. Dore","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079591035","display_name":"John Martin Kaldor","orcid":"https://orcid.org/0000-0002-7639-4355","observed_orcids":["https://orcid.org/0000-0002-7639-4355"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John M. Kaldor","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013176250","display_name":"Margaret Elena Hellard","orcid":"https://orcid.org/0000-0002-5055-3266","observed_orcids":["https://orcid.org/0000-0002-5055-3266"]},"institutions":[{"id":"https://openalex.org/I145902186","display_name":"Burnet Institute","ror":"https://ror.org/05ktbsm52","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I145902186"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Margaret E. Hellard","raw_affiliation_strings":["The Macfarlane Burnet Institute for Medical Research and Public Health, G.P.O. Box 2284, Melbourne, Vic. 3000, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Macfarlane Burnet Institute for Medical Research and Public Health, G.P.O. Box 2284, Melbourne, Vic. 3000, Australia","institution_ids":["https://openalex.org/I145902186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103076687"],"corresponding_institution_ids":["https://openalex.org/I145902186"],"apc_list":{"value":4350,"currency":"USD","value_usd":4350},"apc_paid":null,"fwci":2.0247,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.8605086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"18","issue":"5","first_page":"447","last_page":"451"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/people-who-inject-drugs","display_name":"people who inject drugs","score":0.9869999885559082},{"id":"https://openalex.org/keywords/acute-hepatitis-c","display_name":"acute hepatitis C","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hepatitis-c-treatment","display_name":"hepatitis C treatment","score":0.7110000252723694},{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.718999981880188},{"id":"https://openalex.org/keywords/recruitment-barriers","display_name":"recruitment barriers","score":0.6190000176429749},{"id":"https://openalex.org/keywords/participant-retention","display_name":"participant retention","score":0.5879999995231628},{"id":"https://openalex.org/keywords/multidisciplinary-care","display_name":"multidisciplinary care","score":0.7850000262260437},{"id":"https://openalex.org/keywords/social-support","display_name":"social support","score":0.671999990940094},{"id":"https://openalex.org/keywords/financial-barriers","display_name":"financial barriers","score":0.5899999737739563},{"id":"https://openalex.org/keywords/transport-barriers","display_name":"transport barriers","score":0.8259999752044678},{"id":"https://openalex.org/keywords/legal-issues","display_name":"legal issues","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hiv-hcv-coinfection","display_name":"HIV/HCV coinfection","score":0.8069999814033508},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8404678106307983},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.6452711820602417},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6277604699134827},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.6204046607017517},{"id":"https://openalex.org/C2781400479","wikidata":"https://www.wikidata.org/wiki/Q11640","display_name":"Outreach","level":2,"score":0.48773130774497986},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.4804191589355469},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4543610215187073},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.37863051891326904},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36382436752319336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34850090742111206},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23574906587600708},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.12052446603775024},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007407","descriptor_name":"Interviews as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010348","descriptor_name":"Patient Care Team","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012959","descriptor_name":"Socioeconomic Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015819","descriptor_name":"Substance Abuse, Intravenous","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015819","descriptor_name":"Substance Abuse, Intravenous","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.drugpo.2007.01.007","doi":"https://doi.org/10.1016/j.drugpo.2007.01.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drugpo.2007.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S60503757","display_name":"International Journal of Drug Policy","issn_l":"0955-3959","issn":["0955-3959","1873-4758"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Policy","raw_type":"journal-article"},{"id":"pmid:17854736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17854736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International journal on drug policy","raw_type":"Case Reports"},{"id":"pmh:oai:unsworks.unsw.edu.au:1959.4/unsworks_46780","doi":null,"is_oa":true,"landing_page_url":"http://handle.unsw.edu.au/1959.4/unsworks_46780","pdf_url":null,"source":{"id":"https://openalex.org/S4377196481","display_name":"UNSWorks (UNSW Sydney)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I31746571","host_organization_name":"UNSW Sydney","host_organization_lineage":["https://openalex.org/I31746571"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"},{"id":"pmh:oai:unsworks.library.unsw.edu.au:1959.4/unsworks_46780","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1959.4/unsworks_46780","pdf_url":null,"source":{"id":"https://openalex.org/S4377196481","display_name":"UNSWorks (UNSW Sydney)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I31746571","host_organization_name":"UNSW Sydney","host_organization_lineage":["https://openalex.org/I31746571"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Drug Policy, 18, 5, 447-451","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"pmh:oai:unsworks.unsw.edu.au:1959.4/unsworks_46780","doi":null,"is_oa":true,"landing_page_url":"http://handle.unsw.edu.au/1959.4/unsworks_46780","pdf_url":null,"source":{"id":"https://openalex.org/S4377196481","display_name":"UNSWorks (UNSW Sydney)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I31746571","host_organization_name":"UNSW Sydney","host_organization_lineage":["https://openalex.org/I31746571"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5331793696","display_name":"Treatment of recently acquired hepatitis C virus infection","funder_award_id":"R01DA015999","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320310619","display_name":"Burnet Institute","ror":"https://ror.org/05ktbsm52"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1965380793","https://openalex.org/W1995580832","https://openalex.org/W1996810729","https://openalex.org/W2027545702","https://openalex.org/W2036397891","https://openalex.org/W2037595198","https://openalex.org/W2067488588","https://openalex.org/W2067632007","https://openalex.org/W2089262324","https://openalex.org/W2090720925","https://openalex.org/W2093299818","https://openalex.org/W2094416250","https://openalex.org/W2098618513","https://openalex.org/W2099927113","https://openalex.org/W2110107338","https://openalex.org/W2112876622","https://openalex.org/W2122913585","https://openalex.org/W2124420117","https://openalex.org/W2127685726","https://openalex.org/W2138434459","https://openalex.org/W2154628753","https://openalex.org/W2156515503","https://openalex.org/W2161893095","https://openalex.org/W2169986198","https://openalex.org/W2340554622"],"related_works":["https://openalex.org/W2041934554","https://openalex.org/W2013735801","https://openalex.org/W3017340496","https://openalex.org/W7067188235","https://openalex.org/W7135961137","https://openalex.org/W2007312063","https://openalex.org/W2781158063","https://openalex.org/W2402281140","https://openalex.org/W3149882576","https://openalex.org/W2033605805"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}